Sign Out
Breast cancer: Capecitabine in combination with docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy. Previous therapy should have included an anthracycline.
Capecitabine is also indicated as monotherapy for the treatment of patients with locally advanced or metastatic breast cancer after failure of a taxane and an anthracycline-containing chemotherapy regimen or for whom further anthracycline therapy is not indicated.
Colon and colorectal cancer: Capecitabine is indicated as adjuvant treatment of patients with colon cancer.
Capecitabine is indicated for the treatment of patients with metastatic colorectal cancer.
Oesophagogastric cancer: Capecitabine is indicated as first-line treatment of patients with advanced oesophagogastric cancer.
Gastric cancer: Capecitabine in combination with oxaliplatin is indicated as adjuvant treatment of patients following complete resection of stage II and III gastric adenocarcinoma.
Continue with Google